NEWSROOM

PRESS RELEASE

Nova Minerals to Highlight Estelle Project Advancements at 2024 ThinkEquity Conference

Nova Minerals to Highlight Estelle Project Advancements at 2024 ThinkEquity Conference

Oct 21, 2024

Management to Present at 8.30-9.00 AM on Wednesday, October 30, 2024, in South Salon I Estelle Project Positioned as a World-Class Gold and Antimony Asset with Multi-Million Ounce Resources Anchorage, Alaska, Oct. 21, 2024 - PRISM MediaWire - Nova Minerals Limited (“Nova” or the “Company”) (NASDAQ: NVA) (ASX: NVA) (FRA: QM3), a gold, antimony and critical minerals exploration and development company focused on advancing the Estelle Project in Alaska, will present its latest drill results and...

StemSation International Announces Execution of a Letter of Intent (LOI) to Acquire Gorilla Marketing Group, LLC

StemSation International Announces Execution of a Letter of Intent (LOI) to Acquire Gorilla Marketing Group, LLC

Oct 21, 2024

StemSation International announced today the execution of a Letter of Intent outlining the terms for the acquisition of the private marketing company, Gorilla Marketing Group, LLC Plantation, Florida, October 21, 2024 - PRISM MediaWire - StemSation International (OTC: STSN), a South-Florida based company that has licensed technology for the production and distribution of flavored, canned oxygen products is announcing the execution of a Letter of Intent that outlines the terms and milestone...

Pyxis Tankers to Present at the 2024 ThinkEquity Conference

Pyxis Tankers to Present at the 2024 ThinkEquity Conference

Oct 21, 2024

Maroussi, Greece, October 21, 2024 - PRISM MediaWire - Pyxis Tankers Inc. (NASDAQ Cap Mkts: PXS), (“we”, “our”, “us”, the “Company” or “Pyxis Tankers”), an international shipping company, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients and other industry professionals to highlight groundbreaking innovations and financial...

Cyabra to Present at the ThinkEquity Conference in New York City on October 30

Cyabra to Present at the ThinkEquity Conference in New York City on October 30

Oct 21, 2024

New York, NY, October 21, 2024 - PRISM MediaWire - Cyabra Strategy Ltd.(“Cyabra”),a leading provider of an AI-powered solution for combating worldwide disinformation, today announced that Dan Brahmy, Chief Executive Officer and Co-Founder, will present in person at the ThinkEquity Conference in New York, NY, on Wednesday, October 30, 2024, at 12:00pm ET. Management will also hold one-on-one investor meetings on site during that same day. To schedule a meeting, please contact your ThinkEquity...

American Shared Hospital Services Announces Key Management Appointments

American Shared Hospital Services Announces Key Management Appointments

Oct 18, 2024

Hires Gary Delanois, Seasoned Radiation Oncology Services Executive, as Chief Operating Officer Promotes Ranjit Pradhan to Senior Vice President of Sales and Marketing SAN FRANCISCO, CA, October 18, 2024 - PRISM MediaWire - American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy cancer treatment systems and services, today announced the appointment of Gary Delanois as...

Roadzen to Present at the ThinkEquity Investor Conference October 30, 2024

Roadzen to Present at the ThinkEquity Investor Conference October 30, 2024

Oct 18, 2024

NEW YORK, October 18, 2024 - PRISM MediaWire - Roadzen Inc. (Nasdaq: RDZN) ("Roadzen" or the "Company”), a global leader in AI at the convergence of insurance and mobility, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other industry professionals to highlight groundbreaking innovations and financial strategies. Rohan...

Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference

Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference

Oct 18, 2024

NEWTOWN, Pa., Oct. 18, 2024 - PRISM MediaWire - Helius Medical Technologies, Inc. (“Helius” or the “Company”) [Nasdaq: HSDT], a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that it plans to participate in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other industry professionals...

Universal Media Group, Inc.’s award-winning TV show Before The Fame with Mike Sherman has been nominated for a Suncoast Emmy for the third consecutive year

Universal Media Group, Inc.’s award-winning TV show Before The Fame with Mike Sherman has been nominated for a Suncoast Emmy for the third consecutive year

Oct 17, 2024

Miami, FL., October 17th, 2024 - PRISM MediaWire - Universal Media Group, Inc. (OTC: UMGP), headquartered in Boca Raton, Florida, is the production company behind the Emmy-nominated television show Before The Fame with Mike Sherman. The show has just earned its third consecutive nomination from the Suncoast Emmy committee, this time for a special episode featuring music superstar Shaggy. In this episode, Shaggy sits down with Mike Sherman to discuss his remarkable journey, from serving in the...

BioStem Technologies Reports Breakthrough Results in a Diabetic Foot Ulcer Wound Closure Study Comparing BioREtain® to Standard of Care Treatment

BioStem Technologies Reports Breakthrough Results in a Diabetic Foot Ulcer Wound Closure Study Comparing BioREtain® to Standard of Care Treatment

Oct 17, 2024

Retrospective Study demonstrates clinical efficacy and statistical support for tissue processed via BioREtain to care for treatment-resistant chronic wounds Study published in the peer-reviewed journal, ‘International Wound Journal’ POMPANO BEACH, Fla., Oct. 17, 2024 - PRISM MediaWire - BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived biologics for advanced wound care, announces breakthrough...

Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles

Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles

Oct 16, 2024

IRVINE, Calif., Oct. 16, 2024 - PRISM MediaWire - Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, announced today that CEO Josh Riggs is scheduled to present at the 17th annual Main Event, hosted by LD Micro, on Tuesday, October 29th in Los Angeles. Oncocyte management will also be available for one-on-one meetings with investors. To schedule a one-on-one meeting, please contact Julie Silber at PCG Advisory (jsilber@pcgadvisory.com) or request a meeting via the LD Micro...

SKYX Announces a Collaboration with Wayfair for its Advanced and Smart Plug & Play Lighting for Retail and Professional Segments including Designers and Architects

SKYX Announces a Collaboration with Wayfair for its Advanced and Smart Plug & Play Lighting for Retail and Professional Segments including Designers and Architects

Oct 16, 2024

SKYX will Offer a Variety of its Advanced and Smart Plug & Play Lighting and Ceiling Fan Products, Plug & Play Retrofit Kits and Recessed Lights, Ceiling Outlet Receptacles, and More Miami, FL. October 16, 2024 – PRISM MediaWire - SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive smart platform technology company with over 97 issued and pending patents in the U.S. and globally, with a mission to make homes and buildings become smart, safe, and...

Join the Biofuels Brazil Forum 2024!

Join the Biofuels Brazil Forum 2024!

Oct 16, 2024

Biofuels Brazil Forum 2024 Join the Biofuels Brazil Forum 2024! New York, October 15, 2024 - We are pleased to announce that PRISM Mediawire will be one of the official Media partners for the upcoming International Investment Forum Biofuels Brazil 2024, which will take place from November 27 to 28, 2024, in São Paulo, Brazil. This forum is the premier platform for biofuel producers, regulatory bodies, government officials, technology pioneers, equipment suppliers, engineering companies, and...

4VITAHEALTH Launches Groundbreaking Mental Health Supplements

4VITAHEALTH Launches Groundbreaking Mental Health Supplements

Oct 15, 2024

Tucson, Arizona, October 15, 2024 - PRISM MediaWire - 4VITAHEALTH, a pioneering mental health and wellness supplement company, is proud to announce the launch of its all-natural, made in the USA supplements designed to support brain health and enhance mental well-being. The Epidemic of Sleep Deprivation, Low Mood, and Brain Fog In the United States, approximately 30% of the population (around 100 million people) suffer from sleep deprivation, 23% (around 60 million people) experience some type...

BioStem Technologies Reports Breakthrough Results in a Diabetic Foot Ulcer Wound Closure Study Comparing BioREtain® to Standard of Care Treatment

BioStem Technologies Establishes National Pricing for Vendaje AC® from the Center for Medicare Services and Provides Reimbursement in All MAC Regions

Oct 15, 2024

Vendaje AC to launch across MAC regions nationwide through Venture Medical, the Company’s exclusive sales and marketing partner for AmnioWrap2® POMPANO BEACH, Fla., Oct. 15, 2024 - PRISM MediaWire - BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today announced that the Center for Medicare Services (CMS) has established national pricing for its allograft...

Sono-Tek Reports Fiscal Second Quarter and First Half 2025 Financial Results, Record Backlog and Provides Revenue Guidance

Sono-Tek Reports Fiscal Second Quarter and First Half 2025 Financial Results, Record Backlog and Provides Revenue Guidance

Oct 15, 2024

Q2 Sequential Revenue Growth Meets Quarterly Guidance of 2%-5% Record Equipment and Service Backlog of $11.7 Million First Half Revenue Growth of 10% YOY, First Half Net Income Growth of 13% YOY Expects Continued Revenue Growth for Full Fiscal Year 2025 Conference Call Today at 10:00 am ET MILTON, N.Y., October 15, 2024 – PRISM MediaWire - Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today reported financial results for the second...

Co-Founder of Shire Pharmaceuticals Appointed as Chief Operating Officer of Klotho Neurosciences

Co-Founder of Shire Pharmaceuticals Appointed as Chief Operating Officer of Klotho Neurosciences

Oct 15, 2024

KLTO strengthens team with industry veteran and is poised to accelerate the development of its therapeutic candidates New York, NY, October 15, 2024 - PRISM MediaWire - Klotho Neurosciences, Inc. (NASDAQ: KLTO), a U.S.-based biotechnology company pioneering cell and gene therapies for aging and age-related diseases, today announced the appointment of Peter Moriarty, Co-Founder of Shire Pharmaceuticals, as its Chief Operating Officer (COO). “We are thrilled to have Peter join Klotho...

Lipella Pharmaceuticals Announces U.S. Patent Allowance for Innovative Liposomal Drug Delivery Platform

Lipella Pharmaceuticals Announces U.S. Patent Allowance for Innovative Liposomal Drug Delivery Platform

Oct 15, 2024

Patent application covers key technology innovations for delivering therapeutic agents Proprietary technology enables precise delivery to improve safety and efficacy in oncology, cancer survivorship and immunotherapy Allowance provides broad IP protection for drug-delivery platform and extends market exclusivity for two lead clinical assets currently in Phase 2 trials PITTSBURGH, PA, October 15, 2024 - PRISM MediaWire - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO), a clinical-stage...

SPZI: JP 3E Holdings, Inc. Accelerates Growth with Major Corporate Milestones Toward Uplisting

SPZI: JP 3E Holdings, Inc. Accelerates Growth with Major Corporate Milestones Toward Uplisting

Oct 14, 2024

NEW YORK, October 14, 2024 – PRISM MediaWire - JP 3E Holdings, Inc. (OTC: SPZI), formerly Spooz, Inc., is excited to announce a series of significant corporate developments that mark a new era of growth and expansion for the company. These strategic initiatives include steps to uplist to the OTCQB market, filing a Form 10, following which, it will initiate 15c2-11 filing, become a fully reporting company under SEC guidelines, remove the "shell risk" designation, and implement a comprehensive...

In Light of World Mental Health Day, PRISM Highlights Mental Health Index Companies Making a Difference

In Light of World Mental Health Day, PRISM Highlights Mental Health Index Companies Making a Difference

Oct 10, 2024

New York, New York, October 10, 2024 - PRISM MediaWire - PRISM MediaWire - Mental health has not always been a topic to discuss as easily as other health related topics due to the stigma surrounding it. Those who have identified having a mental health condition typically do not seek the proper help or treatment for fear of judgement or admission to being unstable. The reality of it is that whether or not you have a condition, we all need to do things to ensure we have good mental health in the...

Lipella Pharmaceuticals Announces U.S. Patent Allowance for Innovative Liposomal Drug Delivery Platform

Lipella Pharmaceuticals to Present at 2024 Maxim Healthcare Virtual Summit

Oct 9, 2024

PITTSBURGH, Oct. 09, 2024 - PRISM MediaWire - Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on addressing serious diseases with significant unmet needs, today announced that CEO Jonathan Kaufman, PhD will be presenting at the 2024 Maxim Healthcare Virtual Summit that is being held on October 15 -17, 2024. Event: Lipella Presentation - 2024 Maxim Healthcare Virtual Summit Date: Thursday, October 17th, 2024...

SKYX Announces a Collaboration with Wayfair for its Advanced and Smart Plug & Play Lighting for Retail and Professional Segments including Designers and Architects

SKYX Provides Corporate Update, including Significant Insider Buying

Oct 9, 2024

MIAMI, Oct. 09, 2024 - PRISM MediaWire - SKYX (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive smart platform technology company with over 97 issued and pending patents in the U.S. and globally, and which owns over 60 lighting and home décor websites with a mission to make homes and buildings become smart, safe, and advanced as the new standard, provides today a corporate update including significant insider buying. SKYX Secures $11 million equity preferred stock investment...

Oncocyte’s DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial

Oncocyte’s DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial

Oct 8, 2024

Results published in peer-reviewed journal, Clinical Cancer Research Study validates DetermaIO’s utility in identifying breast cancer patients most likely to benefit from atezolizumab DetermaIO targets a multi-billion-dollar addressable market in oncology diagnostics IRVINE, Calif., October 8, 2024 - PRISM MediaWire - Oncocyte Corp. (Nasdaq: OCX), a diagnostics technology company, announced the peer-reviewed publication of positive data related to its proprietary gene expression test,...

Sono-Tek Reports Fiscal Second Quarter and First Half 2025 Financial Results, Record Backlog and Provides Revenue Guidance

Sono-Tek Announces Fiscal Second Quarter and First Half 2025 Earnings Conference Call

Oct 8, 2024

Conference Call on Tuesday, October 15, 2024 at 10:00 am ET MILTON, NY, October 8, 2024 – PRISM MediaWire - Sono-Tek Corporation (NASDAQ: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced that the Company will hold a conference call to discuss its fiscal second quarter and first half 2025 financial results, ended August 31, 2024, on Tuesday, October 15, 2024 at 10:00 am ET. The second quarter and first half FY 2025 financial results press release will...

SKYX Announces a Collaboration with Wayfair for its Advanced and Smart Plug & Play Lighting for Retail and Professional Segments including Designers and Architects

SKYX Secures $11 Million Strategic Investment at $2.00 Per Share, Preferred Stock Convertible, Led by Global Marriott Hotel-Chain Developer, Lance Shaner, Owner of over 60 Hotels, Primarily Marriotts

Oct 7, 2024

Management Emphasizes That It Has Sufficient Cash to Achieve Its Goals Including Recently Announced Collaborations and Being Cash Flow Positive During 2025 The $11 Million Investment includes Leading Builders and Hotel Developers MIAMI, October 07, 2024 - PRISM MediaWire - SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the "Company" or "SKYX"), a highly disruptive smart platform technology company with more than 97 issued and pending patents globally and over 60 lighting and...

AmpliTech Group Announces Receipt of Notice of Allowance for Patents in 5G and Cryogenic Technology For Quantum Computing Applications

AmpliTech Group Announces Receipt of Notice of Allowance for Patents in 5G and Cryogenic Technology For Quantum Computing Applications

Oct 7, 2024

Hauppauge, NY, October 7, 2024 – PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today is pleased to announce that the United States Patent and Trademark Office (USPTO) has issued a Notice of...

Entrevista exclusiva com Newton Santana, Presidente e Diretor da BEVAP Bioenergia, em antecipação ao Biocombustíveis Brasil 2024

Oct 5, 2024

London, October 5, 2024 - PRISM MediaWire - Temos o prazer de compartilhar uma entrevista exclusiva com Newton Santana, Presidente e Diretor da BEVAP Bioenergia, em antecipação ao Biocombustíveis Brasil 2024 que acontecerá nos dias 27 e 28 de novembro em São Paulo. Newton Santana, Presidente e Diretor da BEVAP Bioenergia Nesta conversa perspicaz, Newton revela as estratégias de ponta da BEVAP para manter a liderança em inovação e sustentabilidade, ao mesmo tempo que oferece uma perspectiva...

Exclusive interview with Newton Santana, President and Director of BEVAP Bioenergy, ahead of Biofuels Brazil 2024

Oct 5, 2024

London, October 5, 2024 - PRISM MediaWire - We are pleased to share an exclusive interview with Newton Santana, President and Director of BEVAP Bioenergy, ahead of Biofuels Brazil 2024, which will take place on November 27-28 in São Paulo. Newton Santana, President and Director of BEVAP Bioenergy In this insightful conversation, Newton reveals BEVAP's cutting-edge strategies to maintain leadership in innovation and sustainability while offering a glimpse into the future of the biofuels...

Entrevista exclusiva con Newton Santana, Presidente y Director de BEVAP Bioenergía, en anticipación a Biocombustibles Brasil 2024

Oct 5, 2024

Londres, October 5, 2024 - PRISM MediaWire - Nos complace compartir una entrevista exclusiva con Newton Santana, Presidente y Director de BEVAP Bioenergía, en anticipación a Biocombustibles Brasil 2024, que se llevará a cabo los días 27 y 28 de noviembre en São Paulo. Newton Santana, Presidente y Director de BEVAP Bioenergía En esta conversación perspicaz, Newton revela las estrategias de vanguardia de BEVAP para mantener el liderazgo en innovación y sostenibilidad, al mismo tiempo que ofrece...

Oncocyte Signs Leading Transplant Centers in US and Germany

Oncocyte Signs Leading Transplant Centers in US and Germany

Oct 2, 2024

GraftAssure™ research assay adopted by two research hospitals that are top-five-in-country by organ transplant volume Company clears first stage gate in clinical product development process and has submitted a Q-Sub to the FDA IRVINE, Calif., Oct. 02, 2024 - PRISM MediaWire - Oncocyte Corporation (Nasdaq: OCX) (“Oncocyte” or the “Company”), a diagnostics technology company, today announced that its new customers include two leading transplant university hospitals in the U.S. and Germany. Both...

Oncocyte Signs Leading Transplant Centers in US and Germany

Oncocyte Corporation Announces $10.2 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules

Oct 2, 2024

Company Obtains Participation from New and Existing Investors, Including Strategic Partner Bio-Rad Laboratories IRVINE, Calif., Oct. 02, 2024 - Oncocyte Corporation (Nasdaq: OCX) (“Oncocyte” or the “Company”), a diagnostics technology company, today announced that it has entered into a securities purchase agreement (the “Purchase Agreement”) with new and existing investors, including Bio-Rad Laboratories, Inc., one of the Company’s strategic partners. The gross proceeds to the Company from the...